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Abstract: 
Iron complex chemistry that opens a new door to the 
medicinal and pharmaceutical worlds is the aim of this research. 
Specifically, ortho-quinone methide moieties are intermediates 
in several antitumor drugs and have been identified as 
bioreductive alkylators of DNA. In our research, a class of iron 
compounds has been targeted to resemble these quinone methides. 
It is hoped that these new compounds could be modified to 
provide a window of opportunity toward the discovery of a 
selective mode of drug delivery. We have focused our efforts on 
generating a reactive transition metal complexed 5-membered 
ring analog of o-quinone methide based on our earlier reports 
of CpFe(CO)z(butadienyl) complexes. In this vein, we have 
elaborated this chemistry by preparing and reacting a 
lithionaphthalene allene with CpF e( CO) j. which gave the desired 
naphthalene annulated sigma complex. This complex thermally 
rearranged to the desired naphthalene annulated 5-membered 
ring quinone methide analog. Upon photolysis, this complex 
successfully mimicked its antecedent and alkylated alcohols. 
Tluts, we here report our initial study of the preparation and 
chemistry of a transition metal complexed 5-membered ring 
quinone methide analog. Its reactions with alcohols have 
accomplished the first step toward the ultimate goal of selectively 
alf...')·lating DNA. 
Introduction: 
Cancer has become a prevalent disease facing many people 
of the world today. Naturally, its ubiquitous and devastating 
character has led many attempts to synthesize a suitable drug for 
combat. Fortunately, scientists have determined the benevolent 
nature of quinone methides and their alk-ylation of nucleic acids 
as an effective mechanism for anticancer antibiotics. Ortho-
quinone methide moieties are believed to be intermediates of 
several antitumor drugs. 
Quinone methides are a class of compounds in which one 
of the oxygen atoms of a quinone is replaced by a methylene (or 
substituted methylene) group. The reactivity of quinone methides 
is mainly electrophilic in nature, which can also be directly 
correlated to their toxicological properties. If the alkylation 
process is achieved under mild, ideally biological, conditions, it 
could be used in a number ofbiomolecular applications. In fact, 
these reactive intermediates have been used as DNA alkylating 
agents and crosslinkers.1 Compounds that react through quinone 
methide and related intermediates moieties couple to the amino 
groups of guanine (Nl) and adenine (N6) bases primarily to 
modify nitrogen nucleophiles; they also couple to the oxygen 
functional groups, most notably the phosphate and ribose oxygens 
as well as (02) of cytosine and (06) of guanine. The specificity 
of DNA alkylation depends greatly on the reaction pathway and 
the ability of the reactive intermediate to associate with particular 
nucleotide sequences or helical confrrmations.2 
As to the nature of quinone methides, they, especially the 
simple ones, are unstable and are often not isolable in a pure 
form. Instead, they rapidly polymerize upon concentration of 
their dilute solutions. So far, no "simple" quinone methide has 
been isolated, except for cases in which the quinone methide 
moiety is part of a fused aromatic system with little contribution 
from the quinone methide form. The observed stability of such 
a complex could only be attributed to the formation of a strong 
metal-olefin bond that remains stable even at the expense of the 
loss of aromaticity of the quinone methide.3 Therefore, the key 
to synthesizing these intramolecular metal-quinone methide 
complexes is to retain the reactive nature of the quinone methide 
complexes so that it can subsequently interact and modify 
reagents, such as DNA. 
The marriage of organometallic chemistry and drug design 
has only lightly been explored.4 Recently, the Allison group has 
targeted a class of organometallic compounds that resembles 
quinone methides and may possess potential DNA alkylation 
abilities. Specifically, we chose a research pathway (shown in 
Figure 1) that would focus on the preparation and chemistry of 
a selected (h1-C5H5)Fe(C0)2-(h1-pentatrienyl) complex that 
should mimic new medicines.5 
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In efforts to synthesize these compounds, previous studies 
of the Allison group found that in general, butadienyl iron 
complexes converted to hydroxyferrocenones in very high yields 
as outlined in Schemel. 6•7 The synthesis of the starting butadienyl 
complexes 2 was carried out with ease; yet, in the past, efforts to 
prepare compounds needed for our project, i.e. the analogous 
pentatrienyl sigma complex, had not been successful. (See 
Scheme 2.) The reason for this failure was thought to be due to 
an intermediate 4 in the mechanism that gives complex 5. This 
mechanism is shown in Scheme 3, in which pentatrienyllithium 
attacks the carbonyl to form 4, followed by concomitant alkyl 
migration and iodide displacement to give 5. 
We suspected that intermediate 4 was responsible for 
previous stumbling blocks in preparation of the pentatrienyl 
complex. Instead of the pathway shown in Scheme 3, it was 
thought that the intermediate underwent cyclization to give an 
undesired complex 6 and ultimately decomposed as shown in 
Scheme4. 
We carried out model theoretical calculations for an organic 
compound that corresponded to 4 and found that the conversion 
of 4 to 6 was favorable by -20kcallmol. This estimate related the 
ease of the undesired cyclization to occur, followed by 
decomposition. In light of this problem, we sought a pentatrienyl 
ligand that contained a key annulated aromatic moiety. 
Compounds that are classified as aromatic are characterized 
to be cyclic, having conjugated double bonds with delocalized 
electrons. Aromatic compounds exhibit unusual stability. This 
gain in stability is due to resonance energy and is the result of the 
de localized and overlapping orbitals of the p electrons. With the 
annulated aromatic naphthalene moiety of the pentatrienylligand 
in 4¢AR, we hoped that the complex would be blocked from the 
undesired cyclization, i.e. 6¢AR, and facilitate migration to form 
the preferred iron complex J.8 (See Scheme 5.) Such would be 
true if the energy required to break the arornaticity of the ring was 
too much to allow cyclization to occur. Our synthesized 
pentatrienyl complex would then possess DNA alkylation 
potential. 
Methods: 
The experimental design consisted of beginning with the 
applicable 1-bromo-2-methylnaphthalene (7) and performing a 
series of reactions to synthesize the desired :~:?-naphthalene 
annulated pentatrienyl quinone methide complexes. The series 
of reactions are shown in Scheme 6. 
Step 1: Preparation of 1-Bromo-2-
bromomethylnaphthalene ( 8 ). A round-bottomed flask equipped 
with a magnetic stir bar was fitted with an air condenser. The 
bromo-methylnaphthalene 7 (19mL, 122mmol), NBS (24.175g, 
160.75mmol), and 500mL ofCC14 were placed inside the flask 
and irradiated with a 250W flood lamp for 20h while stirring. The 
product was recrystallized in hot hexanes to give a mass product 
8 of26.095g in 71.3% yield. 
Step 2: Preparation of 1-Bromo-2-
hydroxymethylnaphthalene (9). A round-bottomed flask was 
equipped with a magnetic stir bar, and complex 8 (26.095g, 
86.98mmol), CaC03 (44.784g, 447.84mmol), 250mL of 
deionized water, and 250mL of P-dioxane were added. The 
reaction was refluxed at 90"C for 16h while stirring. The solution 
was then allowed to cool. The organic product was collected by 
being dissolved in 600mL of CH2Cl2 and 800mL of IM HCI. 
After separation, the organic phase was washed three times with 
IOOmL portions of saturated NaHC03 and dried over MgS04• 
The product was recrystallized in hot hexanes to give a mass 
product 9 of 9.08g in 44% yield. 
Step 3: Preparation of 1-Bromo-2-carbaldehyde 
naphthalene ( 10 ). Complex 9 (6.5g, 27 .3mmol) was dissolved in 
180mL of CH2Cl2• In a round-bottomed flask, PCC (11.75g, 
54.4mmol), the naphthalene solution, and a stir bar were placed. 
The reaction flask was fitted with an air condenser and allowed 
to stir for 1.5h. Ether (40mL) was added to the reaction mixture, 
and the black gum was washed with two IOmL portions of ether. 
This organic phase was passed through a column of a 1-in.layer 
of celite wet with ether. The product was purified over a column 
of silica gel in 10% ether/pentane solution. The mass product 10 
was 5.907g in 92%yield. 
Step 4: Preparation of Acetic acid 1-(2-bromonaphthalen-
1-yl)hept-2-ynyl ester (11). In a large oven-dried Schlenk tube, 
a magnetic stir bar was added, and N2 atmosphere was established. 
Dry ether (75mL) and 1-hexyne (lmL, 8.8mmol) were added. 
The reaction flask was submerged in an ice bath. N-BuLi ( l.6M, 
5.5mL, 8.8mmol) was added dropwise over a period of 5min. 
The solution was allowed to stir IOmin. In a small oven-dried 
Schlenk tube of N2 atmosphere, complex 10 ( l.872g, Smmol) 
was quickly added, and the flask was degassed three times. The 
aldehyde was dissolved in 85mL of dry ether. The aldehyde 
solution was added to the reaction mixture over a period of 
1 Omin, and it was allowed to stir for 1.5h. After having warmed 
to room temperature, to the reaction flask was added lOOmL of 
ether and 75mL of DI H,O. After separation, the organic was 
washed twice with 75mL portions of DI Hp and dried over 
MgSO 4• The product was purified by passing it over silica gel in 
ether. The mass product 11 was 2.562g in 89% yield. 
Step 5: Preparation of 2-Bromo-1-(3-meth_ylhepta-1,2-
dienyl)naphtha/ene (12). In a large oven-dried Schlenk tube, a 
magnetic stir bar was added and N, atmosphere was established. 
Quickly, LiBr (2.345g, 27mmol) and Cui (5.142g, 27mmol) 
were added to the flask. The flask was degassed three times. The 
reagents were dissolved in 90mL of dry ether and allowed to stir 
30min in an ice bath. MeMgBr (3M, 9mL, 27mmol) was added 
dropwise over a period of 5min. The reaction was stirred 30min. 
In a small oven-dried Schlenk tube ofN, atmosphere, complex 
11 (3.2g, 8.9mmol) was added and dissolved in 25mL of dry 
ether. This solution was added dropwise to the reaction mixture 
over a period of 5min, the ice bath was removed, and the solution 
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was allowed to stir for 24h. To extract the compound, 40mL of 
DI Hp and 50mL of ether was added to the Schlenk tube. The 
solution was filtered over a B, chner funnel. After the addition of 
50mL of ether and 30mL of saturated NH4Cl, the filtrate was 
separated. The organic phase was washed three times with 30mL 
portions of DI Hp and dried over MgS04• The product was 
purified by passing it through silica gel in 2% ether/pentane 
solution. The mass product 12 was 1.828g in 65% yield. 
Step 6: Preparation of I}-Pentatrienyl Sigma Complex 
( 13 ). To a medium oven-dried Schlenk tube, a magnetic stir bar 
was added and N 2 atmosphere was established. Dry THF (20mL) 
and complex 12 (l.008g, 3.2mmol) were added to the Schlenk 
tube. The tube was placed in an acetone/dry ice bath at -88=C. 
It was allowed to stir I Omin. Over a period of 5min, 1.6M n-BuLi 
(2.2mL, 3.52mmol) was added. The solution was allowed to stir 
for I h. In a small oven-dried Schlenk tube of N2 atmosphere, 
quickly Fpi (0.623g, 3.52mmol) was added, and after a N2 
atmosphere had been re-established, the crystals were dissolved 
in 8mL of dry THF. Over a period of I Omin, the Fpi solution was 
added to the medium Schlenk tube. After stirring I Omin, the ice 
bath was removed, and stirring was continued for an additional 
20min. The reaction mixture was coated with 8.8g of 6% water/ 
alumina gel. It was immediately transferred to the top of a N
2 
saturated 6% water/alumina column, keeping in mind that this 
product is unstable in the presence of air. The product was eluted 
at a rate of one drip per second with 2.5% ether/pentane solution. 
The mass product 13 was 0.8I4g with a 62% yield. 
Conversion of 2/-Pentatrienyl Sigma Complex to 5-
MemberedRing Quinone Methide Complexes(l4). Complex 13 
was thermodynamically converted to 14 by placing it in a dry 
flask in dark atmosphere over a period of two weeks. This 
quinone methide complex was purified by passing it through aN
2 
saturated 6% water/alumina column with 2.5% ether/pentane 
solution. Two bands were present with remnants of complex 13 
eluting first off the column followed by the complex 14. 
Al!..ylation Reactions. Fours mall aliquots of the 5-membered 
ring quinone methide complexes were dissolved in I.5mL of 
CDCI3 and placed in a NMR tube. IOmL (10 equivalents) of 
diethylamine, 5mL (4 equivalents) of ethanol, 20mL (20 
equivalents) of methanol, and I OmL( I Oequivalents) of methanol 
were placed in the tubes, respectively. The first three tubes were 
placed in an ice bath of O"C, and the last tube was placed in a dry 
ice/acetone bath of -78°C.AII reactions were photolyzedat75W. 
These reactions were monitored through Nuclear Magnetic 
Resonance. See Figures 4, 5, 6, and 7 for results. 
Results and Discussion: 
Preparation of the desired h3-naphthalene annulated 
pentatrienyl quinone methide analog was successfully 
accomplished as shown in Scheme 6. Reaction of I-bromo-2-
carbadehyde naphthalene (10) with hexynyllithium followed by 
acylation gave 11 in an 89% yield. Reaction of 11 with Cui I 
MeMgBr yielded the allene 12 in 65% yield. Reaction of the 
naphthalene annulated vinyl allene bromide 12 with n-BuLi 
followed by (C5H5)Fe(C0)2I gave sigma complex 13 in 62% 
yield. This h1-sigma complex is identified through 1H-NMR by 
its characteristic peaks at d 6.76 and d 5.08. The absorption at d 
6.76 has an integration of I, resulting from the single proton on 
the allene, and the peak at d 5.08 has an integration of 5, resulting 
from the 5 protons on the cyclopentadienyl group. [See Figure 
2.] 
At room temperature, this compound was cleanly converted 
to the diasterometric stable quinone methide complexes 14 with 
a half-life of two weeks. The compound is identified through 1 H-
NMR by characteristic peaks at d 4.I2 and d 3.52, 3.58. The 
former allene peak at d 6. 7 6 had disappeared, and two new peaks 
had appeared at ca. d 3.5 with an integration of I; this represents 
the single proton on the h3 -complex. Also, the peak at d 5.08 had 
shifted to d 4.12, representing the 5 protons on the 
cyclopentadienyl group. [See Figure 3.] 
Initial alkylation reactions were performed to mimic the 
quinone methide analog reactions in the presence of cancerous 
DNA. The test reagents chosen (diethylamine, ethanol, and 
methanol) all represented the characteristics of amine or alcohol 
groups contained on DNA. In the process of alkylation, the 
quinone methide analog would attach itself to DNA; this reactivity 
is a key factor in the nature of an anticancer drug. The results of 
the four reactions (Figures 4, 5, 6, and 7) reveal that there were 
definite changes in the course of the reactions as compared to the 
1H-NMR spectrum of the quinone analog starting complex 
(Figure 3). In all four reactions, a set of twin novel peaks are 
formed at d 6.45, 6.55. However, more tests must be done on the 
products of the alkylation reactions to accurately determine what 
is exactly happening, ifDNA alkylation is indeed occurring, and 
what is being formed. 
One can note that when comparing the methanol reactions 
at 0 and -78°C (Figures 6 and 7) the ideal condition for photolysis 
is in a dry ice/propanol solution of -78°C. Here, the reaction was 
much cleaner and would better facilitate identification of the 
newly formed products. This alkylation reaction with methanol 
at -78°C was recently submitted for analysis via Electrospray 
Mass Spectroscopy. However, there has not been sufficient time 
to thoroughly analyze the results and begin the process of 
identifying the products of the alkylation reaction. 
Indefinitely, this research project has provided a strong 
foundation in the chemistry of transition metal pentatrienyl 
complexed 5-membered ring quinone methide analog. It has 
proven successful in the synthesis of the desired complex. Thus, 
we have made a contributable step toward the potential of an 
anticancerous drug. With a promising future, we can continue in 
further research to study alkylation reactions with this newly 
synthesized product. 
3
Means: Synthesis and Chemistry  of Naphthalene Annulated Trienyl Iron Co
Published by ScholarWorks@UARK, 2002
CHEMISTRY AND BIOCHEMISTRY: Traci Means Naphthalene Annulated Trienyl Iron Complexes 123 
References: 
1) Rokita, Steven E.; Yang, Jianhong; Pande, Praveen; Greenberg, 
William A. "Quinone Methide Alkylation of Deoxycytidine." J. Org. 
Chem. 1997, 62, 3010-3012. 
2) Modica, Emilia; Zanaletti, Riccardo; Freccero, Mauro;Mella, Mariella. 
"Alkylation of Amino Acids and Glutathione in Water by 0-Quinone 
Methide. Reactivity and Selectivity."]. Org. Chern. 2001, 66,41-52. 
3) Vigalok, Arkadi; Milstein, David;" Advances in Metal Chemistry of 
Quinonoid Compounds: New Types of Interactions between Metals and 
Aromatics." Ace. Chern. Res. 2001,34,798-807. 
4) Dagani, R. "Organometallic Chemistry Opens New Vistas in Medi-
cine, Material Science" Chern. Eng. News 1995, AprillO, 32-36. 
5) Ouyang, A.; Skibo, E. B. "Design of a Cyclopropyl Quinone Methide 
Reductive Alkylating Agent"]. Org. Chern. 1998, 63, 1893-1900. 
6) Yongskulrote, W.; Bramlett, J. M.; Mike, C. A.; Durham, B.; Allison, 
N. T. "Photochemical Conversion of (h1-butadienyl)iron Complexes to 
Hydroxyferrocenes" Organometallics 1989, 8, 556. 
7) Dawson, D.P.; Yongskulrote, W., Bramlett, J. M.; Wright, J. B.; 
Durham, B.; Allison, N. T. "Photolysis of (h5-C5H5)Fe(C0)2(butadienyl) 
Complexes. Synthesis and Electrocyclic Ring Closure of (h5-
C5H5)Fe(pentadienoyl) Complexes to Hydroxyferrocenes" Organome-
tallics 1994, 13,3873-3880. 
8) Garratt, P.J. "Aromaticity" John Wiley & Sons, New York, 1986. 
hn, 00 
Schemel 
~ As hn 
Oc, .. oFe'- ..r-=(. -/ _F"(_-;- H -co 
OC R R3 
2 Scheme 2 
35-50% 
Li~=(Me Q n-Bu 
-
~ 
I 
Fe 
:~ 
11 H 
0 
~ 
I 
~ 
I 
OH 
3 
4
Inquiry: The University of Arkansas Undergraduate Research Journal, Vol. 3 [2002], Art. 18
http://scholarworks.uark.edu/inquiry/vol3/iss1/18
'' 
'' 
.. ' 
\\'# I 
., ' 
I 
1>' 
1' 
. ' 
' ' 
124 INQUIRY Volume 3 2002 
4 
«+=» G> I u 
OC•"•Fe9 ~' ~~ n-Bu 
4(AR 
;}' 
Scheme3 
4 
Scheme4 
6 
SchemeS 
alkyl 
migration 
cyclization 
5 
decomposition 
6(AR 
5
Means: Synthesis and Chemistry  of Naphthalene Annulated Trienyl Iron Co
Published by ScholarWorks@UARK, 2002
; 
~ 
~ 
~ 
CHEMISTRY AND BIOCHEMISTRY: Traci Means Naphthalene Annulated Trienyl Iron Complexes 125 
Sdlemei 
Btb Bq; NBS 
HP 
7 8 
Bct;H . 1.n-Bu~ 
_ 2. Ac20 
~ 
0 
~ 
0 
!::: 
~ 
~ 
~ 
0 
... 
0 
.. 
0 
... 
0 
.. 
0 
.,; 
0 
... 
0 
.., 
0 
.. 
~ 
0 
10 
0 
Figure 2 
9.0 
11 
I 
~e_-co 
u-1~H3 ~ n·Bu 
14a 
: Sigma ADelle COIIIplu 13 
r .. 
' ;! 
~ 
~utJ -
a.o 7.1:1 
X:putS.,....MiWoa: lH 
+ 
---
~--~ --
.... 
.. 
:0 
"l 
.. 
6.0 u 
PCX::: 
9 
1. nBuli 
12 13 
-- -·--- ---·~-------- - /~ 
~ I'" I H n-Bu 
oo··FetS ex! - . CtiJ 
~ !J ~ 
i~ 
13 "' 
~ ... 
~ 
r JL__jl'~ ~ '-{, 1L 
<1.0 3.0 2.0 1.0 0 
6
Inquiry: The University of Arkansas Undergraduate Research Journal, Vol. 3 [2002], Art. 18
http://scholarworks.uark.edu/inquiry/vol3/iss1/18
126 INQUIRY Volume 3 2002 
r:J 
I "' I 
l 
Figure 3: S-Membered Ring Quinoae Methide Complexes 14 __ --------·---- .. 
+ 
·-·----· ····--l 
~ 
I 
~v---g,- n-Bu 
i ~-
1 
14a 
I ~ 
l ~ 
0 
,.; 
0 
... 
li 
q 
,: 
oi ~ 
10.0 
r j~~ 1:~~\ 1 1 A~ llt:. ~~\~ v1 1-----j·-r-·-_..,.. -~ ~ :'----;-: ---::;······)...--'.·, 1_.1'.._!-. ~, ;-~·a ·.I. '----'! ,:~ 6.0 s.o -4.o 310 2.0 1.0 9.0 8.0 
X : parts per Million : I H 
Figure 4: Diethylamine Alkylation Rnctiou 
10.0 9.0 8.0 7.0 4.0 2.0 1.0 
h X : pam per Million : I H 
7
Means: Synthesis and Chemistry  of Naphthalene Annulated Trienyl Iron Co
Published by ScholarWorks@UARK, 2002
CHEMISTRY AND BIOCHEMISTRY: Traci Means Naphthalene Annulated Trienyl Iron Complexes 127 
Fipre 5: Ethanol Alkylation Keacuoa 
r-~~~-,--------------------------------------------------------~----------
0 
• 
0 
... 
tl. X : pans per Million : J H 
h 
0 
.,; 
10.0 9.0 3.0 
X:-pcrMilJioa: IH 
%.0 1.0 0 
7.0 s.o 
8
Inquiry: The University of Arkansas Undergraduate Research Journal, Vol. 3 [2002], Art. 18
http://scholarworks.uark.edu/inquiry/vol3/iss1/18
128 INQUIRY Volume 3 2002 
0 
... 
Figure 7: Methuol Alkylation ~ctioo at -78"C 
""'':.:::- _J,J ... -. ·C 1VL ,..._.~~~J,... .-;; 
't''"' .Q/1" ._.- --~~. • OJ......._,.-· "'""" - -~ -
9:o· · · · '"· · ···s~O · · ·-·. ···-·;~-~.....-.-.;_; -.....--~' · · .-.s~;;~ · ...... ,.., .. ~~-·· .. ~r:· ·-·-;:~·.- • .,-.~-;:;··· "'~, 
arts per Million ~ 1J-!.,. .... 
1.0 0 
hv,-CO ~ I 
Fe ~ 
Faculty Comments: 
Neil Allison. Ms. Means' faculty mentor, is lavish in his 
praise of her work. He says: 
Mv contact with Ms. Means has been extensive. First 
sh~ attended my organic chemistry lab course (Organic 
1, CHEM 3702) that I taught in fall1999. In the spring 
2000, she was enrolled in my organic chemistry lecture 
course (Organic 11, CHEM 3713). At this time she 
decided to carry out honors research work in my 
group. Ms. Means is currently working in my research 
lab on a chemistry problem that focuses on model 
studies of potential anticancer and anti-tumor drugs. 
She has chosen to carry out these studies as her senior 
honor's project in her four-year honors scholar 
program. This course of study is themostacadernically 
rigorous program on our campus. I would say that 
she is truly a multi-task person that solves all problems 
with gusto. Even with all of her obligations, I have 
found that Ms. Means is not a "bookworm" type. She 
is completely honest and reliable. She has an amiable 
personality and is well liked by our faculty and her 
peers. Probably most impressive on the research front 
is that she also is a leader in my laboratory. When she 
is present, all of the students are excited about their 
research! This rare quality is not found in many 
people, and to have a person that is excited about 
research with an effervescent personality really tends 
to ignite the whole lab.The research that Ms. Means is 
currentlyaccomplishingis comparable to what I would 
expect from a good third-year graduate student. She 
grasps theoretical chemical concepts instantly. In fact, 
after she read a grant proposal that I was writing in 
the area of her research, she was able to offer 
suggestions! I would never have expected this from 
an undergraduate student and only would expect a 
third or fourth year graduate student to be mature 
enough for this task. Her laboratory skills are the best 
I've seen from any undergraduate student (and most 
graduate students) in my laboratory. She has 
accomplished a completed project, one that I am 
currently writing up as a communication for 
publicationinanAmericanChernicalSocietyjournal. 
To be published as a communication means that it 
must be "urgent, fast breaking research". In this paper 
wereportthatshehasaccomplishedanewmulti-step 
synthesis of a previously unknown compound. We 
anticipate that this compound will be an important 
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model for a new class of drugs based on an 
organometallic system (something previously 
unknown). All factors considered, of our current 
chemistry students I would rank Ms. Means at the top 
in research. Before corning to this university I studied 
at the UniversityofCalifornia, Berkeley, the University 
of Cologne, and the University of Florida, Gainesville. 
I would rank Ms. Means, at her stage in her career, 
among the best undergraduate students that I've seen 
at these universities. Over the past 22 years, I've 
probably written 160 or so letters of recommendation 
for students, half of whom I would consider as 
outstanding students. Ms. Means is certainly in the 
very top handful (3 to 5) of these students. 
I must also mention, although not related to research, 
that Ms. Means also takes on other, perhaps more 
mature,responsibilities.Throughhercompellingneed 
to help people she is carrying out missionary work in 
a very impoverished area of Haiti for two months this 
summer and during spring break. Traci is active in 
helping people. I just found out that she purchases 
food for an elderly woman who is housebound and 
takes it to her apartment. In the past Ms. Means has 
also helped visually impaired students. This includes 
note taking, reading, etc. 
Ms. Means' faculty advisor, Dale Johnson, is also very 
complimentary; hi remarks follow ... 
I have been Traci Means' academic advisor for the 
past four years so I am familiarwithher great academic 
strengths, and I have followed her research through 
conversation with Ms. Means and her mentor Professor 
Allison. Ms. Means is a special student; she is quick to 
grasp concepts and can use them in new situations 
with ease. She has never chosen the easy academic 
path and is completing the four-year honors degree 
leading to a BS in Biophysical Chemistry, perhaps the 
most demanding undergraduate degree option offered 
by the Department of Chemistry and Biochemistry. In 
her own words, "I chose this rigorous major because 
I believe it is interesting, challenging, and will best 
prepare me for my next academic goal, entering 
medical schooL" 
Professor Neil Allison has raved about her work ethic 
and the ease with which she learns laboratory skills. 
Despite a busy academic schedule, she is the most 
productivememberofhisresearchgroup,surpassing 
the output of some of our graduate students. I have 
read a draft of a publication that is in progress based 
extremely impressive. 
onherundergraduate thesis. 
It will be an important 
contribution to both 
organometallic and 
biosynthetic ch.emistry and 
will serve as the foundation 
for a new research direction 
for Allison's research group. 
This is the sort of 
contribution you hope will 
come from the efforts of an 
excellent graduate student. 
To see this productivity from 
an undergraduate is 
A thjrd chemjstry profes or, Wally Cordes, equally 
enthu iastic about Ms. Mean ' research. He says ... 
It is easy to say positive things aboutTraci Means. The 
expectations of the chemistry department are high; 
even so, the research independence developed by Ms. 
Means is extraordinary, and her over-all academic 
record is equally outstanding. 
Professor Allison has had a large number of excellent 
undergraduate students work in his lab during his 
tenure here, and for him to say that Ms. Means is 
about the besthehasever had is a significantstatement. 
The research she has done is not a trivial project: the 
extremely air-sensitive rna terials she has worked with 
require the highest level of experimental technique. 
And the chemical reactions she has developed and 
perfected are all very sophisticated organic reactions. 
In reading the abstract of her work I can see how Dr. 
Allisoncomparesittotheworkofathird-yeargraduate 
student. Organic synthesis is not an easy kind of 
research for an undergraduate student to pursue; it 
requires more patience and perseverance than many 
other kinds of chemical research. There are many 
minor details that must be handled to have decent 
yields of final products. In most cases of an 
undergraduate student doing this kind of research 
one expects the student to make daily visits to the 
research director asking foradviceonhow to overcome 
"the problem of the day". That's whyitalso impresses 
me when Dr. Allison said Ms. Means would go to the 
lab and attack these problems on her own, so that by 
the next time he saw her she would tell him how she 
had solved the problems and attained the desired 
results. 
The research will be submitted for publication in one 
of the highest prestige research journals of the 
American Otemical Society, and I'm confident it will 
be published. In addition to the organic chemistry 
developed, it has important pertinence to the "hot" 
area of research for selective drug delivery. 
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